Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle

Saved in:
Bibliographic Details
Main Authors: Philipp M. Lepper, Martha Triantafilou, Luke A. O'Neill, Natalija Novak, Hermann Wagner, Andrew E. Parker, Kathy Triantafilou
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2010/705612
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568244850917376
author Philipp M. Lepper
Martha Triantafilou
Luke A. O'Neill
Natalija Novak
Hermann Wagner
Andrew E. Parker
Kathy Triantafilou
author_facet Philipp M. Lepper
Martha Triantafilou
Luke A. O'Neill
Natalija Novak
Hermann Wagner
Andrew E. Parker
Kathy Triantafilou
author_sort Philipp M. Lepper
collection DOAJ
format Article
id doaj-art-be76b1be66c14f01b88474cad75f4be5
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-be76b1be66c14f01b88474cad75f4be52025-02-03T00:59:27ZengWileyMediators of Inflammation0962-93511466-18612010-01-01201010.1155/2010/705612705612Modulation of Toll-Like Receptor Signalling as a New Therapeutic PrinciplePhilipp M. Lepper0Martha Triantafilou1Luke A. O'Neill2Natalija Novak3Hermann Wagner4Andrew E. Parker5Kathy Triantafilou6Department of Internal Medicine V—Pneumology, Allergology and Respiratory Intensive Care Medicine, Saarland University Hospital, 66421 Homburg, GermanyInfection and Immunity Group, Department of Child Health, School of Medicine, University of Cardiff, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UKSchool of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, IrelandDepartment of Dermatology and Allergology, University of Bonn, 53012 Bonn, GermanyInstitute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, 80333 Munich, GermanyInstitute of Molecular Medicine, Trinity Centre for Health Sciences, St. James' Hospital, Dublin 8, IrelandInfection and Immunity Group, Department of Child Health, School of Medicine, University of Cardiff, University Hospital of Wales, Heath Park, Cardiff CF14 4XN, UKhttp://dx.doi.org/10.1155/2010/705612
spellingShingle Philipp M. Lepper
Martha Triantafilou
Luke A. O'Neill
Natalija Novak
Hermann Wagner
Andrew E. Parker
Kathy Triantafilou
Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
Mediators of Inflammation
title Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
title_full Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
title_fullStr Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
title_full_unstemmed Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
title_short Modulation of Toll-Like Receptor Signalling as a New Therapeutic Principle
title_sort modulation of toll like receptor signalling as a new therapeutic principle
url http://dx.doi.org/10.1155/2010/705612
work_keys_str_mv AT philippmlepper modulationoftolllikereceptorsignallingasanewtherapeuticprinciple
AT marthatriantafilou modulationoftolllikereceptorsignallingasanewtherapeuticprinciple
AT lukeaoneill modulationoftolllikereceptorsignallingasanewtherapeuticprinciple
AT natalijanovak modulationoftolllikereceptorsignallingasanewtherapeuticprinciple
AT hermannwagner modulationoftolllikereceptorsignallingasanewtherapeuticprinciple
AT andreweparker modulationoftolllikereceptorsignallingasanewtherapeuticprinciple
AT kathytriantafilou modulationoftolllikereceptorsignallingasanewtherapeuticprinciple